Patent details

EP2609928 Title: Use of cannabinoids in combination with Aripiprazole

Basic Information

Publication number:
EP2609928
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP131526006
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of cannabinoids in combination with Aripiprazole
French Title of Invention:
Utilisation de cannabinoides en combinaison avec de l'Aripiprazole
German Title of Invention:
Verwendung von Cannabinoiden in Kombination mit Aripiprazol
SPC Number:

Dates

Filing date:
17/12/2008
Grant date:
17/07/2019
EP Publication Date:
03/07/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/07/2019
EP B1 Publication Date:
17/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2019
Expiration date:
17/12/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/07/2019
 
 

Name:
GW Pharma Limited
Address:
Sovereign House, Histon Cambridge CB24 9BZ, United Kingdom (GB)

Inventor

1

Name:
Guy, Geoffrey
Address:
United Kingdom (GB)

2

Name:
Kikuchi, Tetsuro
Address:
Japan (JP)

3

Name:
Robson, Philip
Address:
United Kingdom (GB)

4

Name:
Maeda, Kenji
Address:
Japan (JP)

5

Name:
Stott, Colin
Address:
United Kingdom (GB)

Priority

Priority Number:
0800390
Priority Date:
04/01/2008
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/05; A61K 31/35; A61K 31/352; A61K 36/185; A61K 45/06; A61P 25/18; A61P 25/22;

Publication

European Patent Bulletin

Issue number:
201929
Publication date:
17/07/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages